Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity | MicrobiomeTrials← Back to trialsNCT05713799
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2030-03-01
Enrollment target: 60 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis
Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the…
Columbia, United StatesCompleted Mar 1, 2031
Nephrotic SyndromeLipodystrophyMetabolic SyndromeHealthy VolunteerDiabetesMetabolic Associated Steatotic Liver Disease
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn mo…
Bethesda, United StatesEst. completion Feb 1, 2030